Optimizing small molecule therapeutics to treat focal segmental glomerulosclerosis
Ended Project Grant Awarded Last action
- Award ID
- HT94252310480
- Recipient
-
University Of Pittsburgh - Of The Commonwealth System Of Higher Education UEI MKAGLD59JRL1
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $2,806,431
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Pittsburgh, PA, USA
Award details come from USAspending.gov.
About this award
The University of Pittsburgh was awarded a $2,806,431.00 Project Grant on July 1, 2023 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to optimize small molecule therapeutics to treat focal segmental glomerulosclerosis. This basic, applied, and advanced biomedical research aims to transform health care by developing innovative and impactful medical solutions for Service Members and the American public. The University of Pittsburgh will leverage its expertise in quantum materials to conduct early-stage research at the intersection of nanoscience and quantum physics that could enable future quantum technologies. The period of performance is from July 1, 2023 to June 30, 2026.
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| Trustees Of The University Of Pennsylvania | $165,090 | |
| The Trustees Of The University Of Pennsylvania | $160,188 |
Quick answers
Who received award HT94252310480?
HT94252310480 was awarded to University Of Pittsburgh - Of The Commonwealth System Of Higher Education by Defense Health Agency (Department of Defense) on July 1, 2023.
How much is award HT94252310480 worth?
$2,806,431 has been obligated on HT94252310480.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award